Pfizer launches sixth Pfizer CARES CSR Report

ENBREL® offers new treatment device option for rheumatoid arthritis patients

Pfizer launches its first Reconciliation Action Plan, commits to closing the gap

MYLOTARG™PBS listed in Australia for patients with previously untreated, acute myeloid leukemia

TGA approves Pfizer's novel COVID-19 oral treatment in Australia

Pfizer to Provide Australia with 500,000 Courses of Oral Treatment for COVID-19

Pfizer Australia transitions to wholesaler distribution model

Pfizer and BioNTech Achieve Approval by Medsafe For Their Vaccine Against COVID-19

Pfizer and BioNTech Achieve Approval by TGA for Their Vaccine Against COVID-19

Impressive speaker line-up for next Pfizer Invites webinar

Towards a National Medicines Traceability Framework Consultation Paper

Cost Recovered Pathway for Medical Services Advisory Committee

Pfizer Australia 22-23 Pre-Budget Submission

Pfizer Australia National Medicines Policy Review Submission